Migraines are severe headaches, often with nausea and sensitivity to light or sound. Menstrual migraines (MM) happen around a woman's period. This study tests how well a new drug, ubrogepant, works for MM. **Ubrogepant** is a new medicine being tested to see if it can help with these headaches.
450 women in the U.S. and Puerto Rico will be part of the study. They will get either the medicine or a fake pill (placebo) for 7 days each month over 16 weeks. If eligible, they can continue for another 52 weeks. Participants will keep a daily diary and visit the clinic regularly. The researchers will check the medicine's effects with tests and questions. Some people might find this study more demanding than their usual care.
- The study lasts for about 1 year with regular clinic visits.
- Participants will take medicine or placebo for 7 days each month.
- Daily diary entries are needed to track symptoms and side effects.
How understandable was the trial content above?
Hard to understand
Easy to understand